About Artificial Intelligence in Medicine
Artificial Intelligence in Medicine is a Healthcare company based in Toronto (Canada) founded in 2013, and was acquired by Inspirata in January 2018. AI software solutions for cancer surveillance and research are developed. It operates in the Healthcare and Technology sectors. Its chief executive, as recorded, is Jack Golabek. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.
Company details
Artificial Intelligence in Medicine was founded in 2013 in Toronto, Canada. AI-based software solutions are offered for cancer surveillance, prevention, research, biobanking, and medical laboratory operations. The product portfolio features Arbevio, by which AI and natural language processing are utilized to construct searchable databases from lab reports, clinic visit records, and similar sources in the healthcare sector.
Investors in Artificial Intelligence in Medicine
Artificial Intelligence in Medicine has secured backing from 1 investor. Prominent investors backing the company include Inspirata.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Digital pathology solutions for cancer diagnostics are developed by Inspirata. | 2014 | inspirata.com | Tampa, United States |
Investor details for Artificial Intelligence in Medicine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Artificial Intelligence in Medicine
1 people are tracked at Artificial Intelligence in Medicine (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jack Golabek | CEO | Leadership |
Complete people profiles for Artificial Intelligence in Medicine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Artificial Intelligence in Medicine
2 dated milestones of Artificial Intelligence in Medicine across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Artificial Intelligence in Medicine is founded.
- Exit Acquired by Inspirata.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Artificial Intelligence in Medicine
Artificial Intelligence in Medicine was founded in 2013.
Artificial Intelligence in Medicine is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Jack Golabek is the CEO of Artificial Intelligence in Medicine, as recorded in our data.
Artificial Intelligence in Medicine was founded in 2013 in Toronto, Canada. AI-based software solutions are offered for cancer surveillance, prevention, research, biobanking, and medical laboratory operations. The product portfolio features Arbevio, by which AI and natural language processing are utilized to construct searchable databases from lab reports, clinic visit records, and similar sources in the healthcare sector.
Artificial Intelligence in Medicine has 1 investor. Key investors include Inspirata.
Yes. Artificial Intelligence in Medicine was acquired by Inspirata in January 2018.
